NuCana is trading 9% higher at $1.09 in pre-market, with the move’s catalyst unclear.

  • Schwab’s November 4 headline listing showed no headlines for the company that day.
  • Broader markets were higher in the supplied pre-market context and may have been supportive.
  • Available evidence does not establish broader markets as the direct cause.